Background Correctly staging lung cancer is important because the treatment options and
prognosis differ significantly by stage. Several noninvasive imaging studies and invasive …

Positron emission tomography is an evolving imaging tool that is becoming increasingly
available for use in clinical practice. This overview will look at the current evidence for the …

Positron emission tomography (PET) using 2-18 F-fluoro-2-deoxy-D-glucose (FDG), a
radioactive derivative of glucose, is an advanced imaging tool, based on the increased …

The rationale was to develop recommendations on the use of 18F-FDG PET in breast,
colorectal, esophageal, head and neck, lung, pancreatic, and thyroid cancer; lymphoma …

Background Correctly staging lung cancer is important because the treatment options and
the prognosis differ significantly by stage. Several noninvasive imaging studies including …

OBJECTIVE. The purpose of our study was to evaluate the reliability of software-calculated
doubling times for discerning malignant versus benign nodules. MATERIALS AND …

The solitary pulmonary nodule (SPN) has always been a diagnostic challenge for the
radiologists. Currently, with increased utilization of computed tomography (CT) greater …

In patients who have a high likelihood of having lung cancer, there is little role for positron
emission tomography (PET) imaging for diagnosis of the primary lesion. The primary impact …

Lung cancer is the most common cancer, worldwide, and a major health issue with a
remarkable mortality rate. 2-[18 F] fluoro-2-deoxy-D-glucose positron emission …

Since its introduction in 1974, positron emission tomography (PET) has gained widespread
use, especially in diagnosis and staging of lung cancer. In this respect, 18F …